There's been a notable change in appetite for Carl Zeiss Meditec AG shares in the week since its yearly report, with the stock down 15% to €49.30. Revenues were €2.1b, approxi ...

Despite a challenging fiscal year, Carl Zeiss Meditec AG (CZMWF) leverages new product launches and strategic market ...

I've made no secret about my liking for the MedTech company Carl Zeiss Meditec (OTCPK:CZMWF). This is, to my mind one of the best companies in MedTech not only due to the company's portfolio ...

The broader Asia-Pacific region was also a weak spot, with organic growth in ophthalmology devices down 4.5% for the year, ...

EQS-News: Carl Zeiss Meditec AG / Key word (s): Annual Report/Annual Results Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved 11.12.2024 ...

ZEISS Industrial Quality Solutions, the global leader in cutting-edge metrology and inspection technologies and software, ...

RBC Capital analyst Jack Reynolds-Clark maintained a Hold rating on Carl Zeiss Meditec (0DHC – Research Report) today and set a price target of €70.00. The company’s shares closed yesterday at €58.93.

Carl Zeiss Meditec's stock continues to face significant market challenges, with shares trading at €55.70 on XETRA, marking a 1.2% decline. This downturn represents a dramatic shift from the company's ...

German optics giant Carl Zeiss AG has signaled a major commitment ... The center represents a deeper integration of the Indian team into the company's global operations. Manufacturing expansion ...

Many may say the camera is key, and now the new version of Nokia hopes to stand out by putting Carl ... company's whole business model was based on strategic partnerships and the key thing about ...

ZEISS and Mindpeak partner to advance Multiplex Immunofluorescence (mIF) solutions for pathology ...